jRCTs052240103RecruitingNot Applicable
Randomized controlled trial comparing root canal filling using resin sealer without gutta-percha point to using conventional technique of root canal filling. (MSSP RCT )
Not provided0 sites384 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 384
- Primary Endpoint
- -
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized Controlled Trial
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment Purpose
- Masking
- Open(masking Not Used)
Eligibility Criteria
- Ages
- 18age 0month 0week old over to 90age 0month 0week old not (—)
- Sex
- All
Inclusion Criteria
- •(1) Diagnosis of irreversible pulpitis, pulp necrosis, or apical periodontitis based on pulp and periodontal histology and imaging (dental radiographs and dental cone-beam CT).
- •(2) It has been determined that healing is possible by root canal treatment using the standard method.
- •(3) The patient is between 18 and 90 years of age at the time of consent and is capable of consenting.
- •(4) The patient's condition is expected to be stable for at least 12 months from the time consent is obtained.
- •(5) Written consent to participate in this study has been obtained from the patient.
Exclusion Criteria
- •(1) Has an allergy to raw materials used for root canal filling sealer.
- •(2) With horizontal or vertical root fracture.
- •(3) Perforation difficult to repair and removal of foreign body in root canal difficult to remove.
- •(4) Traffic between periodontal pocket and root canal lesion.
- •(5) History of root tip resection and intentional replantation.
- •(6) It is judged that normal root canal treatment is extremely difficult due to morphological reasons of the root canal, such as dens invaginatus.
- •(7) Patient has a deciduous tooth and a stenotic root canal, and the final magnification of root canal formation is #35 or less.
- •(8) Diagnosed with diabetes mellitus.
- •(9) Patients who are judged to be inappropriate as research subjects by the principal investigator or a sub investigator for other reasons.
Outcomes
Primary Outcomes
-
Evaluation of periodontal tissue at the root apex using CBCT and clinical symptoms
Secondary Outcomes
No secondary outcomes reported
Investigators
Similar Trials
Not yet recruiting
Phase 2
COMPARISION BETWEEN TWO BLOCKS FOR POST OPERATIVE ANALGESIACTRI/2023/06/053548GOVERNMENT MEDICAL COLLEGE, AMRITSAR
Recruiting
Not Applicable
Second trimester abortion with previous lower segment scarCTRI/2022/01/039442SDM College of medical sciences and hospital
Completed
Phase 1
The Cancer Molecular Screening and Therapeutics (MoST) Program Substudy addendum 1: PalbociclibCancer - Any cancerCancerACTRN12616000931471niversity of Sydney16
Active, not recruiting
Phase 1
A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF SINGLE-AGENT LENALIDOMIDE (REVLIMID) IN PATIENTSWITH MANTLE CELL NHL WHO HAVE RELAPSED OR PROGRESSED AFTER TREATMENT WITH BORTEZOMIB OR ARE REFRACTORY TO BORTEZOMIB - NDPATIENTS WITH MANTLE CELL NHL WHO HAVE RELAPSED OR PROGRESSED AFTER TREATMENT WITH BORTEZOMIB OR ARE REFRACTORY TO BORTEZOMIBMedDRA version: 9.1Level: HLTClassification code 10026798Term: Mantle cell lymphomasEUCTR2007-007756-34-ITCelgene Corporation133
Recruiting
Phase 2
Cancer Molecular Screening and Therapeutics (MoST) Program Addendum 19 substudies 41-42: SotorasibCancer - Any cancerCancerACTRN12621001690842The University of Sydney32